434 related articles for article (PubMed ID: 23577497)
21. Prescription behaviours for tigecycline in real-life clinical practice from five European observational studies.
Bassetti M; Eckmann C; Bodmann KF; Dupont H; Heizmann WR; Montravers P; Guirao X; Capparella MR; Simoneau D; Sánchez García M
J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii5-14. PubMed ID: 23772047
[TBL] [Abstract][Full Text] [Related]
22. Empiric antibiotic selection strategies for healthcare-associated pneumonia, intra-abdominal infections, and catheter-associated bacteremia.
Snydman DR
J Hosp Med; 2012; 7 Suppl 1():S2-S12. PubMed ID: 23737334
[TBL] [Abstract][Full Text] [Related]
23. Antimicrobial Lessons From a Large Observational Cohort on Intra-abdominal Infections in Intensive Care Units.
Vogelaers D; Blot S; Van den Berge A; Montravers P;
Drugs; 2021 Jun; 81(9):1065-1078. PubMed ID: 34037963
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology and Risk Factors for Isolation of Multi-Drug-Resistant Organisms in Patients with Complicated Intra-Abdominal Infections.
Labricciosa FM; Sartelli M; Abbo LM; Barbadoro P; Ansaloni L; Coccolini F; Catena F
Surg Infect (Larchmt); 2018 Apr; 19(3):264-272. PubMed ID: 29298133
[TBL] [Abstract][Full Text] [Related]
25. Empiric antibiotic selection strategies for healthcare-associated pneumonia, intra-abdominal infections, and catheter-associated bacteremia.
Snydman DR
J Hosp Med; 2012; 7 Suppl 1():S2-12. PubMed ID: 23677631
[TBL] [Abstract][Full Text] [Related]
26. Current guidelines for the treatment of severe pneumonia and sepsis.
Bodmann KF
Chemotherapy; 2005 Aug; 51(5):227-33. PubMed ID: 16103664
[TBL] [Abstract][Full Text] [Related]
27. Prospective, randomized, study of ampicillin-sulbactam versus moxifloxacin monotherapy for the treatment of community-acquired complicated intra-abdominal infections.
Chen CW; Ming CC; Ma CJ; Shan YS; Yeh YS; Wang JY
Surg Infect (Larchmt); 2013 Aug; 14(4):389-96. PubMed ID: 23859673
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for mortality and cost implications of complicated intra-abdominal infections in critically ill patients.
De Pascale G; Carelli S; Vallecoccia MS; Cutuli SL; Taccheri T; Montini L; Bello G; Spanu T; Tumbarello M; Cicchetti A; Urbina I; Oradei M; Marchetti M; Antonelli M
J Crit Care; 2019 Apr; 50():169-176. PubMed ID: 30553184
[TBL] [Abstract][Full Text] [Related]
29. Tigecycline: the answer to beta-lactam and fluoroquinolone resistance?
Fraise AP
J Infect; 2006 Nov; 53(5):293-300. PubMed ID: 16876253
[TBL] [Abstract][Full Text] [Related]
30. Antimicrobial therapy of intra-abdominal sepsis.
Sawyer MD; Dunn DL
Infect Dis Clin North Am; 1992 Sep; 6(3):545-70. PubMed ID: 1431038
[TBL] [Abstract][Full Text] [Related]
31. Complicated intra-abdominal infections: a focus on appendicitis and diverticulitis.
Spirt MJ
Postgrad Med; 2010 Jan; 122(1):39-51. PubMed ID: 20107288
[TBL] [Abstract][Full Text] [Related]
32. In vitro activity of tigecycline against isolates from patients enrolled in phase 3 clinical trials of treatment for complicated skin and skin-structure infections and complicated intra-abdominal infections.
Bradford PA; Weaver-Sands DT; Petersen PJ
Clin Infect Dis; 2005 Sep; 41 Suppl 5():S315-32. PubMed ID: 16080070
[TBL] [Abstract][Full Text] [Related]
33. The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: an executive summary.
Mazuski JE; Sawyer RG; Nathens AB; DiPiro JT; Schein M; Kudsk KA; Yowler C;
Surg Infect (Larchmt); 2002; 3(3):161-73. PubMed ID: 12542922
[TBL] [Abstract][Full Text] [Related]
34. Critical issues in the clinical management of complicated intra-abdominal infections.
Blot S; De Waele JJ
Drugs; 2005; 65(12):1611-20. PubMed ID: 16060697
[TBL] [Abstract][Full Text] [Related]
35. Tigecycline for the treatment of patients with severe sepsis or septic shock: a drug use evaluation in a surgical intensive care unit.
Swoboda S; Ober M; Hainer C; Lichtenstern C; Seiler C; Wendt C; Hoppe-Tichy T; Büchler M; Weigand MA
J Antimicrob Chemother; 2008 Mar; 61(3):729-33. PubMed ID: 18222953
[TBL] [Abstract][Full Text] [Related]
36. The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: evidence for the recommendations.
Mazuski JE; Sawyer RG; Nathens AB; DiPiro JT; Schein M; Kudsk KA; Yowler C;
Surg Infect (Larchmt); 2002; 3(3):175-233. PubMed ID: 12542923
[TBL] [Abstract][Full Text] [Related]
37. Intra-abdominal infections.
Mazuski JE; Solomkin JS
Surg Clin North Am; 2009 Apr; 89(2):421-37, ix. PubMed ID: 19281892
[TBL] [Abstract][Full Text] [Related]
38. Intra-abdominal infections.
Pieracci FM; Barie PS
Curr Opin Crit Care; 2007 Aug; 13(4):440-9. PubMed ID: 17599016
[TBL] [Abstract][Full Text] [Related]
39. Clinical and microbiological efficacy of tigecycline for complicated skin-soft-tissue and intra-abdominal infections in a Turkish university hospital.
Avkan-Oguz V; Yapar N; Alp-Cavus S; Demir Onder K; Aktas E; Gulay Z; Cakır N
Int J Clin Pract; 2013 Jun; 67(6):505-11. PubMed ID: 23679904
[TBL] [Abstract][Full Text] [Related]
40. Changing bacteriology of abdominal and surgical sepsis.
Chen YH; Hsueh PR
Curr Opin Infect Dis; 2012 Oct; 25(5):590-5. PubMed ID: 22744317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
